Clostridium scindens

Name: Clostridium scindens Morris et al. 1985

DSM No.: 5676, Type strain dsm-5676 dsm5676 dsm 5676 Clostridium scindens

Strain designation: 19, VPI 13733

Other collection no. 

or WDCM no.: ATCC 35704

Isolated from: human faeces

Country: United States of America

Date of sampling: before 1984

Nagoya Protocol Restrictions: There are NO known Nagoya Protocol restrictions for this strain.

History: <- ATCC <- L.V. Holdeman, VPI 13733 <- V. Bokkenheuser, 19

Genbank accession numbers: 16S rRNA gene: AF262238

Cultivation conditions: Medium 110 , anaerobic, 35°C 

Medium/media recipe(s) required for preparing 110:

-  Medium 78 

or

Medium 339 with strain-specific modifications, anaerobic, 35°C 

Please follow special instructions: 'Cultivation of Anaerobes'

Complete DSMZ Media List

Summary and 

additional information: <- ATCC <- L.V. Holdeman, VPI 13733 <- V. Bokkenheuser, 19. Human faeces; USA (4133). Type strain. Taxonomy/description (4133). Sequence accession no. 16S rRNA gene: AF262238. Produces 20-alpha-hydroxysteroid dehydrogenase (4135), 7-ß-dehydrogenase (4133), 7-alpha-dehydroxylase (4133). Steroid transformations (4134, 4135). (Medium 110 or Medium 339 with strain-specific modifications, 35°C, anaerobic).

Literature: 4133, 4134, 4135, 5318

Risk group: 1 (classification according to German TRBA)

Supplied as:

Delivery form Prices

Freeze Dried

Active culture on request

DNA  

Price Category for this culture: 1